ORIGINAL PAPER
Clinical characteristics and treatment outcomes of chronic recurrent multifocal osteomyelitis in the population of children from central Poland – observations of one center
1
Department of Paediatric Cardiology and Rheumatology, Medical University of Lodz, Łódź, Poland
Submission date: 2025-01-22
Final revision date: 2025-08-13
Acceptance date: 2025-08-13
Publication date: 2025-11-20
Corresponding author
Justyna Roszkiewicz
Justyna Roszkiewicz, MD, PhD, Department of Paediatric Cardiology and Rheumatology, Medical University of Lodz, 36/50 Sporna St., 91-738 Łódź, Poland
Justyna Roszkiewicz, MD, PhD, Department of Paediatric Cardiology and Rheumatology, Medical University of Lodz, 36/50 Sporna St., 91-738 Łódź, Poland
Pediatr Pol 2025;61(4):323-327
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Chronic recurrent multifocal osteomyelitis (CRMO) is a rare autoinflammatory disease that occurs predominantly in the paediatric population. The disease causes recurrent flares of inflammatory bone pain and typically affects multiple bones. The aim of the study was to evaluate demographic and laboratory data, the overall clinical picture and treatment responses among children and adolescents with this disease entity from central Poland.
Material and methods:
A total of 25 children diagnosed with CRMO between 2016 and 2022 at the Department of Paediatric Cardiology and Rheumatology at the Medical University of Łódź were enrolled in the study. A comprehensive, retrospective review of the clinical, laboratory and radiological data was conducted.
Results:
The median age of onset of the disease was 12 years (range 4–17). The vast majority of patients (68%) were female. The incidence rate of CRMO in central Poland was found to be approximately 1.7/100 000 children/year. 60% of the patients had more than one lesion at the disease onset and male patients were more likely to present with multifocal disease. The most frequently affected bones were tibia (52%) and femur (36%). The mean inflammatory marker values were within normal limits, while the osteocalcin concentration in all of the patients was elevated over the normal range (median concentration 92.4 ng/ml (IQR: 62.6–116.45)). Most of the patients (68%) underwent a whole-body magnetic resonance imaging (MRI) scan that revealed abnormal bone activity of the affected structures. The patients were successfully treated with non-steroidal anti-inflammatory drugs (56%), methotrexate (44%), sulfasalazine (64%) and bisphosphonates (32%).
Conclusions:
Although awareness of CRMO is increasing among clinicians, data from the Polish population is still limited. This study analysed the clinical features, laboratory tests, imaging methods and treatment outcomes. Whole-body MRI has been identified as a relevant screening tool for the diagnosis of CRMO. Further research on CRMO is needed in order to increase awareness and consequently reduce the time to diagnosis.
Chronic recurrent multifocal osteomyelitis (CRMO) is a rare autoinflammatory disease that occurs predominantly in the paediatric population. The disease causes recurrent flares of inflammatory bone pain and typically affects multiple bones. The aim of the study was to evaluate demographic and laboratory data, the overall clinical picture and treatment responses among children and adolescents with this disease entity from central Poland.
Material and methods:
A total of 25 children diagnosed with CRMO between 2016 and 2022 at the Department of Paediatric Cardiology and Rheumatology at the Medical University of Łódź were enrolled in the study. A comprehensive, retrospective review of the clinical, laboratory and radiological data was conducted.
Results:
The median age of onset of the disease was 12 years (range 4–17). The vast majority of patients (68%) were female. The incidence rate of CRMO in central Poland was found to be approximately 1.7/100 000 children/year. 60% of the patients had more than one lesion at the disease onset and male patients were more likely to present with multifocal disease. The most frequently affected bones were tibia (52%) and femur (36%). The mean inflammatory marker values were within normal limits, while the osteocalcin concentration in all of the patients was elevated over the normal range (median concentration 92.4 ng/ml (IQR: 62.6–116.45)). Most of the patients (68%) underwent a whole-body magnetic resonance imaging (MRI) scan that revealed abnormal bone activity of the affected structures. The patients were successfully treated with non-steroidal anti-inflammatory drugs (56%), methotrexate (44%), sulfasalazine (64%) and bisphosphonates (32%).
Conclusions:
Although awareness of CRMO is increasing among clinicians, data from the Polish population is still limited. This study analysed the clinical features, laboratory tests, imaging methods and treatment outcomes. Whole-body MRI has been identified as a relevant screening tool for the diagnosis of CRMO. Further research on CRMO is needed in order to increase awareness and consequently reduce the time to diagnosis.
REFERENCES (16)
1.
Giedion A, Holthusen W, Masel LF, Vischer D. [Subacute and chronic “symmetrical” osteomyelitis]. Ann Radiol (Paris) 1972; 15: 329-342.
2.
Björkstén B, Gustavson KH, Eriksson B, Lindholm A, Nordström S. Chronic recurrent multifocal osteomyelitis and pustulosispalmoplantaris. J Pediatr 1978; 93: 227-231.
3.
Girschick H, Finetti M, Orlando F, Schalm S, Insalaco A, Ganser G, et al. The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry. Rheumatology 2018; 57: 1203-1211.
4.
Ma L, Liu H, Tang H, Zhang Z, Zou L, Yu H, et al. Clinical characteristics and outcomes of chronic nonbacterial osteomyelitis in children: a multicenter case series. Pediatr Rheumatol Online J 2022; 20: 1.
5.
Wipff J, Costantino F, Lemelle I, Pajot C, Duquesne A, Lorrot M, et al. A large national cohort of french patients with chronic recurrent multifocal osteitis. Arthritis Rheumatol 2015; 67: 1128-1137.
6.
Aden S, Wong S, Yang C, Bui T, Higa T, Scheck J, et al. Increasing cases of chronic nonbacterial osteomyelitis in children: a series of 215 cases from a single tertiary referral center. J Rheumatol 2022; 49: 929-934.
7.
Jansson AF, Grote V. Nonbacterial osteitis in children: data of a German Incidence Surveillance Study. ActaPaediatr 2011; 100: 1150-1157.
8.
Chia DT, Toms AP, Sanghrajka A, Ramanan AV, Killeen OG, Ilea C, et al. Incidence of chronic recurrent multifocal osteomyelitis in children and adolescents in the UK and Republic of Ireland. Rheumatology (Oxford) 2024; 64: 2162-2170.
9.
Jansson A, Renner ED, Ramser J, Mayer A, Haban M, Meindl A, et al. Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford) 2007; 46: 154-160.
10.
Roderick MR, Shah R, Rogers V, Finn A, Ramanan AV. Chronic recurrent multifocal osteomyelitis (CRMO) – advancing the diagnosis. Pediatr Rheumatol Online J 2016; 14: 47.
11.
Szkopiecka K, Bednarska I, Gierlich A, Hochman M, Krupińska A, Kucek E, et al. Statistical Yearbook Łódzkie Voivodship 2023.
12.
Johnsson A, Flatø B, Knudsen P, Lilleby V. Clinical outcome in a Norwegian cohort of patients with chronic recurrent multifocal osteomyelitis. Scand J Rheumatol 2015; 44: 513-514.
13.
Al Hajry M, Al Jumaah S, Almayouf SM. Chronic recurrent multifocal osteomyelitis: a first report from Saudi Arabia. Ann Saudi Med 2012; 32: 611-614.
14.
Ziobrowska-Bech A, Fiirgaard B, Heuck C, Hansen OR, Herlin T. Ten-year review of Danish children with chronic non-bacterial osteitis. ClinExpRheumatol 2013; 31: 974-979.
15.
O’Leary D, Al Julandani DA, Zia M, Klotsche J, Minden K, Roderick M, et al. HLA-B27 is associated with CNO in a European cohort. Pediatr Rheumatol Online J 2023; 21: 52.
16.
Khanna G, Sato TSP, Ferguson P. Imaging of chronic recurrent multifocal osteomyelitis. RadioGraphics 2009; 29: 1159-1177.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
